General Practice Research Unit (AFE), Department of General Practice, Institute of Health and Society, Faculty of Medicine, University of Oslo, Post Box 1130 Blindern, 0318, Oslo, Norway.
Centre for Welfare and Labour Research, Norwegian Social Research, OsloMet - Oslo Metropolitan University, Oslo, Norway.
Diabetologia. 2019 Aug;62(8):1337-1348. doi: 10.1007/s00125-019-4905-2. Epub 2019 Jun 15.
AIMS/HYPOTHESIS: Individuals of South Asian origin have a high risk of type 2 diabetes and of dying from a diabetes-attributable cause. Lifestyle modification intervention trials to prevent type 2 diabetes in high-risk South Asian adults have suggested more modest effects than in European-origin populations. The strength of the evidence of individual studies is limited, however. We performed an individual participant data meta-analysis of available RCTs to assess the effectiveness of lifestyle modification in South Asian populations worldwide.
We searched PubMed, EMBASE, Cochrane Library and Web of Science (to 24 September 2018) for RCTs on lifestyle modification interventions incorporating diet and/or physical activity in South Asian adults. Reviewers identified eligible studies and assessed the quality of the evidence. We obtained individual participant data on 1816 participants from all six eligible trials (four from Europe and two from India). We generated HR estimates for incident diabetes (primary outcome) and mean differences for fasting glucose, 2 h glucose, weight and waist circumference (secondary outcomes) using mixed-effect meta-analysis overall and by pre-specified subgroups. We used the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) system to rate the quality of evidence of the estimates. The study is registered with the International Prospective Register of Systematic Reviews ([PROSPERO] CRD42017078003).
Incident diabetes was observed in 12.6% of participants in the intervention groups and in 20.0% of participants in the control groups. The pooled HR for diabetes incidence was 0.65 (95% CI 0.51, 0.81; I = 0%) in intervention compared with control groups. The absolute risk reduction was 7.4% (95% CI 4.0, 10.2), with no interactions for the pre-specified subgroups (sex, BMI, age, study duration and region where studies were performed). The quality of evidence was rated as moderate. Mean difference for lifestyle modification vs control groups for 2 h glucose was -0.34 mmol/l (95% CI -0.62, -0.07; I = 50%); for weight -0.75 kg (95% CI -1.34, -0.17; I = 71%) and for waist -1.16 cm (95% CI -2.16, -0.16; I = 75%). No effect was found for fasting glucose. Findings were similar across subgroups, except for weight for European vs Indian studies (-1.10 kg vs -0.08 kg, p = 0.02 for interaction).
CONCLUSIONS/INTERPRETATION: Despite modest changes for adiposity, lifestyle modification interventions in high-risk South Asian populations resulted in a clinically important 35% relative reduction in diabetes incidence, consistent across subgroups. If implemented on a large scale, lifestyle modification interventions in high-risk South Asian populations in Europe would reduce the incidence of diabetes in these populations.
目的/假设:南亚裔个体患 2 型糖尿病和死于糖尿病相关原因的风险较高。针对高危南亚裔成年人预防 2 型糖尿病的生活方式干预试验表明,其效果不如欧洲裔人群。然而,单个研究的证据强度有限。我们对现有随机对照试验的个体参与者数据进行了荟萃分析,以评估生活方式改变在全球南亚裔人群中的有效性。
我们在 PubMed、EMBASE、Cochrane 图书馆和 Web of Science(截至 2018 年 9 月 24 日)中搜索了针对南亚成年人饮食和/或体力活动的生活方式干预的 RCTs。审查员确定了合格的研究,并评估了证据的质量。我们从六项合格试验中的所有六项试验(四项来自欧洲,两项来自印度)中获得了 1816 名参与者的个体参与者数据。我们使用混合效应荟萃分析总体和按预先指定的亚组生成了新发糖尿病(主要结局)和空腹血糖、2 小时血糖、体重和腰围(次要结局)的 HR 估计值。我们使用推荐评估、制定与评价(GRADE)系统对估计值的证据质量进行评级。该研究已在国际前瞻性系统评价注册中心(PROSPERO:CRD42017078003)进行了注册。
干预组中有 12.6%的参与者发生了糖尿病,对照组中有 20.0%的参与者发生了糖尿病。与对照组相比,糖尿病发生率的合并 HR 为 0.65(95%CI 0.51,0.81;I = 0%)。绝对风险降低为 7.4%(95%CI 4.0,10.2),预先指定的亚组之间没有交互作用(性别、BMI、年龄、研究持续时间和研究进行的区域)。证据质量被评为中等。与对照组相比,生活方式改变组的 2 小时血糖平均差值为-0.34mmol/L(95%CI -0.62,-0.07;I = 50%);体重差值为-0.75kg(95%CI -1.34,-0.17;I = 71%),腰围差值为-1.16cm(95%CI -2.16,-0.16;I = 75%)。空腹血糖没有影响。除了欧洲和印度研究的体重亚组(-1.10kg 与-0.08kg,p=0.02 交互作用)外,结果在各亚组中相似。
结论/解释:尽管肥胖程度有适度的变化,但针对高危南亚裔人群的生活方式干预措施可使糖尿病发病率相对降低 35%,这在各亚组中是一致的。如果在南亚裔高危人群中大规模实施,欧洲的生活方式干预措施将降低这些人群的糖尿病发病率。